Biocair celebrates landmark year of environmental initiatives and strategic growth
Sustainability at the forefront:
In a landmark move towards its goal of becoming a net-zero business by 2040, Biocair introduced 100% electric vans to its Cambridge fleet in April. This step reflects Biocair's dedication to sustainable practices, a commitment that earned the company its second consecutive EcoVadis silver medal in 2023. These efforts underscore Biocair's ongoing strategy to minimize its global environmental footprint while maintaining exceptional service standards.
Strategic partnerships for enhanced efficiency:
2023 saw Biocair forge key partnerships to bolster its supply chain capabilities. In June, a partnership with TrakCel led to the integration of their OCELLOS system, enhancing visibility and automation in the cell and gene therapy supply chain.
Biocair's collaboration with Tive was recognized as one of SupplyChainBrain’s ‘100 Great Supply Chain Partners’ of 2023 in August, highlighting Biocair's commitment to supply chain excellence and innovation.
Additionally, in December Biocair announced a new partnership with Aramex Ireland to expand its presence in the Irish market. Through this partnership, Biocair and Aramex Ireland offer a fully integrated service, including pick-up and delivery, all managed through the Aramex network.
Advancing medical research through partnerships:
This year, Biocair provided critical logistics support to the UK-based contract research organization, FibroFind, in their groundbreaking research into fibrosis drug development. By facilitating over 100 rapid, reliable sample deliveries worldwide, Biocair demonstrated its expertise in handling sensitive, time-critical shipments. This partnership underscores Biocair's role in advancing vital medical research, with each successful delivery contributing to the global fight against fibrosis.
Awards and accolades in the Asia-Pacific region:
Biocair's contributions to the cell and gene therapy field were acknowledged with two awards at the prestigious Asia-Pacific Cell & Gene Therapy Excellence Awards in September. This recognition celebrates Biocair's pivotal role in advancing therapies, research and development in this vital sector.
Global expansion and growth:
Aligning with its growth strategy, Biocair expanded its Edinburgh facility and doubled its Chicago office and warehouse space in 2023. These expansions reflect the increasing demand for Biocair's specialized logistics services and its commitment to enhancing operational capabilities.
"Our achievements in 2023 are a true testament to our teams’ continued commitment, expertise and knowledge across the globe. The strides we've made this year are not just milestones for Biocair but also for the broader life sciences logistics industry. We are excited to continue this trajectory of excellence and innovation in the years to come," states Chris Cooke, Biocair CEO.
For more information visit www.biocair.com.
